CryoCor, Inc.

Company History
CryoCor is a medical technology company that has developed and manufactures a disposable catheter system based on its proprietary cryoablation technology for the minimally invasive treatment of cardiac arrhythmias. The Company's product, the CryoCor Cardiac Cryoablation System, or the Cryoablation System, is designed to treat cardiac arrhythmias through the use of cryoenergy, or extreme cold, to destroy targeted cardiac tissue. The Cryoablation System has been approved in Europe for the treatment of atrial fibrillation, and atrial flutter, the two most common and difficult to treat arrhythmias, since 2002. In the United States, CryoCor has completed enrollment in a pivotal trial to evaluate the safety and efficacy of the Cryoablation System for the treatment of atrial fibrillation and the Cryoablation System has been approved in the United States for the treatment of right atrial flutter.

Current Investors/Backers
CryoCor, Inc. is backed by a group of top tier investors including MPM Capital, William Blair Capital Partners, OrbiMed Advisors, Beecken Petty & Company and Frantz Medical Ventures.

For more information on CryoCor, Inc., please visit their web site at www.cryocor.com